
Bedrijfsprofiel
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows:
- X-ray imaging products (55.4%);
- MRI products (32.7%);
- other (11.9%): contrast products for echography and nuclear medicine, fine chemicals products.
Bron:
Cofisem
-
laatste update:
04 Apr 2025
Bestuurders
Chief Executive Officer | David Hale | ||||
Administrative & Finance Director | Jérôme Estampes | ||||
Chief Communication Officer | Christine Allard | ||||
General Counsel | Charlotte Bamière | ||||
Director of Development | Philippe Bourrinet | ||||
Director Research & Development | François Nicolas | ||||
Chief Innovation Officer | François Nicolas | ||||
Chief Human Resources Officer | Eva Ohlsson | ||||
Bron: Cofisem - laatste update: 04 Apr 2025 |
Kerncijfers
Millenium | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Net sales | 841.093 | 785.690 | 753.275 | 732.071 | 712.295 |
Income from ordinary activities | 851.115 | 795.654 | 761.497 | 735.911 | 712.295 |
Operating income | 49.570 | 38.671 | -18.160 | 38.685 | 41.872 |
Cost of financial indebtedness net | 22.290 | 8.591 | 3.205 | 3.184 | 7.156 |
Equity-accounted companies contribution to income | |||||
Net profit from discontinued activities | |||||
Net income | 13.467 | 22.171 | -41.116 | 32.637 | 18.240 |
Net income (Group share) | 16.084 | 23.866 | -41.116 | 32.637 | 18.240 |
Fiscal year end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
Bron: Cofisem - laatste update: 04 Apr 2025 |
Aandeelhoudersinformatie

Adres
Guerbet
Zone Paris Nord II 15 Rue des Vanesses
FR-93420
Villepinte
France
Telefoonnummer:
+33 (0)1 45 91 50 00
Fax:
+33 (0)1 45 91 51 99
Bron:
Cofisem
-
laatste update:
04 Apr 2025